Literature DB >> 2995967

A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

K Semba, N Kamata, K Toyoshima, T Yamamoto.   

Abstract

From a human genomic library, we obtained six v-erbB-related DNA clones. A DNA probe prepared from one of the clones, lambda 107, hybridized to EcoRI fragments of 6.4 and 13 kilobase pairs of human DNA. Neither of these fragments was amplified in A431 vulva carcinoma cells, in which the gene encoding the epidermal growth factor receptor is amplified. In addition, the probe from lambda 107 hybridized with a single, 4.8-kilobase poly(A)+ RNA species and did not react with EGF receptor mRNA. Thus, we conclude that clone lambda 107 represents a v-erbB-related gene (c-erbB-2) that is distinct from the EGF receptor gene. In contrast, the other five clones were shown to represent the EGF receptor gene (c-erbB-1). Partial nucleotide sequence analysis of the lambda 107 insert showed that this clone contained at least seven putative exons and that six of them could encode the kinase domain characteristic of protein products of the src oncogene family. Southern blot analysis showed close similarity of the restriction patterns of the rat c-erbB-2 gene and the rat neu oncogene, suggesting possible involvement of c-erbB-2 in human cancer. In fact, approximately 30-fold amplification of c-erbB-2 was observed in a human adenocarcinoma of the salivary gland.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995967      PMCID: PMC390744          DOI: 10.1073/pnas.82.19.6497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

2.  A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments.

Authors:  J Messing; J Vieira
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

3.  The erbB gene of avian erythroblastosis virus is a member of the src gene family.

Authors:  T Yamamoto; T Nishida; N Miyajima; S Kawai; T Ooi; K Toyoshima
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Characterization of a human colon/lung carcinoma oncogene.

Authors:  M S McCoy; J J Toole; J M Cunningham; E H Chang; D R Lowy; R A Weinberg
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

6.  Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I.

Authors:  J B Rubin; M A Shia; P F Pilch
Journal:  Nature       Date:  1983 Sep 29-Oct 5       Impact factor: 49.962

7.  A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells.

Authors:  M Schwab; K Alitalo; H E Varmus; J M Bishop; D George
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

8.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.

Authors:  R F Doolittle; M W Hunkapiller; L E Hood; S G Devare; K C Robbins; S A Aaronson; H N Antoniades
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

9.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.

Authors:  M D Waterfield; G T Scrace; N Whittle; P Stroobant; A Johnsson; A Wasteson; B Westermark; C H Heldin; J S Huang; T F Deuel
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

10.  Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells.

Authors:  G T Merlino; Y H Xu; S Ishii; A J Clark; K Semba; K Toyoshima; T Yamamoto; I Pastan
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

View more
  137 in total

Review 1.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

2.  Cytoplasmic expression of c-erbB2 in non-small cell lung cancers.

Authors:  Chun-Mei Cheng; Koichi Tsuneyama; Kazuhiro Matsui; Hiroyuki Takahashi; Shin Ishizawa; Yasuo Takano
Journal:  Virchows Arch       Date:  2005-05-19       Impact factor: 4.064

3.  Identification and characterization of a novel enhancer for the rat neu promoter.

Authors:  D H Yan; M C Hung
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  v-maf, a viral oncogene that encodes a "leucine zipper" motif.

Authors:  M Nishizawa; K Kataoka; N Goto; K T Fujiwara; S Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

6.  Analysis of c-erbB2 protein content of human glioma cells and tumor tissue.

Authors:  H H Engelhard; M Wolters; P S Criswell
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

Review 8.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  Translating insights from the cancer genome into clinical practice.

Authors:  Lynda Chin; Joe W Gray
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

Review 10.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.